Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy
Pablo García‐Pavía(Universidad Francisco de Vitoria), Perry Elliott(St Bartholomew's Hospital), Frank M. Bengel(Medizinische Hochschule Hannover), Dulce Brito(University of Lisbon), Yoshiki Sekijima(Shinshu University), Sharmila Dorbala(Brigham and Women's Hospital), Franz Duca(Medical University of Vienna), Thibaud Damy(Amyloidosis Foundation), Laura Obici(University of Pavia), José Nativi-Nicolau(Jacksonville College), Claudio Rapezzi(University of Ferrara)
Cited by 173
Related Papers
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k